Oxford Cancer Analytics raises $11M to detect lung cancer via a blood test
OXcan combines proteomics and artificial intelligence for early detection
Read more...Late-stage venture capital firm Meritech Capital Partners (MCP) announced Wednesday that it has closed $425 million for its fourth late-stage fund.
The firm’s cumulative capital under management now totals $2.6 billion. MCP IV succeeds MCP III, a $400 million fund started in 2006.
Targeting Internet and Digital Media, Communications and Wireless, Enterprise IT and Medical Devices, MCP IV will make investments ranging in size from $10 to $20 million. Based on Meritech’s past investments, it appears that the firm has little preference in regard to a startup’s location.
Here are a few of the last Meritech-funded startup rounds we’ve covered in the past months:
Other recent investments include Cloudera, Cyan and Tableau. As far as companies that have already seen great success, Meritech’s portfolio boasts Cornerstone OnDemand, Facebook, Fortinet, Intralase, Netezza, Netsuite, Riverbed and Salesforce.
“We see no shortage of investment opportunities given the innovation that is taking place in mobile, virtualization, cloud computing, the social-enabled Internet and data management and analytics,” said George Bischof, managing director at Meritech, in a prepared statement. “If anything, there are a record number of attractive late-stage companies today.”
Meritech currently has four managing directors, but is reported to be announcing a new partner in the next week or so.
OXcan combines proteomics and artificial intelligence for early detection
Read more...Nearly $265B in claims are denied every year because of the way they're coded
Read more...Most expect to see revenue rise, while also embracing technologies like generative AI
Read more...